Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Hold Lloyds Banking Group (LLOY) by Alan Oscroft in The Motley Fool
- Buy Xaar (XAR) by Berenberg
- Sell Corero Network Security (CNS) by Steve Moore in ShareProphets
- Sell Everyman Media Group (EMAN) by Steve Moore in ShareProphets
- Hold BP (BP.) by Tom Winnifrith in ShareProphets
- Hold BP (BP.) by Steve Moore in ShareProphets
- Buy Fresnillo (FRES) by Citi
- Buy RM (RM.) by Steve Moore in ShareProphets
- Buy Capital Limited (DI) (CAPD) by Steve Moore in ShareProphets
- Hold JD Sports Fashion (JD.) by Mark Hartley in The Motley Fool
- Speculative Buy Kodal Minerals (KOD) by Canaccord Genuity
- Buy Renew Holdings (RNWH) by Peel Hunt
- Sell Crimson Tide (TIDE) by Steve Moore in ShareProphets
- Hold Glencore (GLEN) by Harvey Jones in The Motley Fool
- Hold Burberry Group (BRBY) by Harvey Jones in The Motley Fool
- Add Aviva (AV.) by Andrew Mackie in The Motley Fool
- Hold Lloyds Banking Group (LLOY) by Dr. James Fox in The Motley Fool
- Hold BP (BP.) by Harvey Jones in The Motley Fool
- Hold Lloyds Banking Group (LLOY) by Alan Oscroft in The Motley Fool
Verici DX (VRCI) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Verici DX (VRCI)
| Latest Bid : 0.70p | Latest Ask : 0.75p |
| High Today : 0.75p | Low Today : 0.70p |
| This Years High : 5.75p | This Years Low : 0.52p |
| Volume : 336,014 | MKT Cap : £1.82M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Verici DX (VRCI) Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.Verici DX (VRCI) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2025-07-21 11:25:00 21/07/2025 | -50.00% |
| Sell | Steve Moore | Premium Only | 2025-06-11 16:25:00 11/06/2025 | 40.00% |
| Avoid | Steve Moore | Premium Only | 2025-04-07 11:10:00 07/04/2025 | 50.00% |
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 85.00% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 91.18% |
Verici DX (VRCI) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.70p | Latest Ask : 0.75p |
| High Today : 0.75p | Low Today : 0.70p |
| This Years High : 5.75p | This Years Low : 0.52p |
| Volume : 336,014 | MKT Cap : £1.82M |
Verici DX Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Verici DX Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2025-07-21 11:25:00 21/07/2025 | -50.00% |
| Sell | Steve Moore | Premium Only | 2025-06-11 16:25:00 11/06/2025 | 40.00% |
| Avoid | Steve Moore | Premium Only | 2025-04-07 11:10:00 07/04/2025 | 50.00% |
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 85.00% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 91.18% |